Grafrath, Germany

Andreas Schoop

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Schoop

Introduction

Andreas Schoop is a notable inventor based in Grafrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target histone deacetylases. With a total of four patents to his name, Schoop's work has the potential to impact various medical conditions.

Latest Patents

One of Schoop's latest patents involves hetero-halo inhibitors of histone deacetylase. This invention provides compounds that inhibit HDAC2, which are useful for treating, alleviating, or preventing conditions such as neurological disorders, memory or cognitive function disorders, extinction learning disorders, fungal diseases, inflammatory diseases, hematological diseases, and neoplastic diseases. These compounds aim to improve memory and address memory loss or impairment.

Career Highlights

Throughout his career, Schoop has worked with prominent companies in the pharmaceutical industry, including Rodin Therapeutics, Inc. and Alkermes, Inc. His experience in these organizations has allowed him to collaborate on innovative projects that advance medical research and treatment options.

Collaborations

Schoop has collaborated with notable colleagues such as Martin R. Jefson and Fabian Dey. These partnerships have contributed to the development of his patented inventions and have fostered a collaborative environment for innovation.

Conclusion

Andreas Schoop's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…